Bedford, Massachusetts-based Insulet Corp. has joined the ranks of publicly-traded medtech companies, raising $120 million in its initial public offering on May 15. The company offered 7.7 million shares, nearly a million more than originally targeted….TransMedics, Inc. recently announced it has received IDE approval to initiate the pilot phase of its multi-center clinical trial for its Organ Care System™. The trial is designed to enroll 20 patients and will take place at five leading transplant centers in the U.S., including the University of Pittsburgh Medical Center, UCLA Medical Center, The Cleveland Clinic, The University of Chicago Medical Center, and Brigham & Women’s Hospital….Inverness Medical Innovations Inc. has confirmed that it will acquire San Diego-based Biosite in a cash merger transaction of $90 per share. Like Inverness, Biosite markets medical diagnosis products

715 Albany Street, TW1   Boston, MA 02118   tel: 617 414 1340   fax: 617 414 1344   info@massmedic.com